In the meta-analysis conducted by Lohmann et al., obesity was found to be associated with worse DFS and OS across all breast cancer subtypes, including HER2-positive tumors [14]. This evidence concerns the gene ERBB2 and obesity due to melanocortin 4 receptor deficiency.